Table 1 The main steps in the efferocytosis process.

From: Phytochemical-mediated efferocytosis and autophagy in inflammation control

Num

Steps

Factors and pathways

1

Recruitment of phagocytes [42, 174,175,176,177]

-Phagocytes are guided towards ACs by “Find-Me” signals, which act as chemoattractants.

-“Find-Me” signals, such as fractalkine, LPC, S1P, and nucleotides (ATP and UTP), play a crucial role in guiding phagocytes toward ACs.

-These signals not only guide phagocytes but also enhance their ability to clear ACs and trigger anti-inflammatory responses (detailed in step 5).

2

Recognition of ACs [44, 178,179,180,181,182]

-Phagocytes distinguish between phagocytic and non-phagocytic cells through the interaction of ACs’ ligands (“Eat-Me” signals) with receptors present in phagocytes.

-Different ligands present on the surface of ACs, such as PS, ox-LDL, calreticulin (Calr), ICAM3, C1q, and annexin I, are recognized by engulfment receptors on phagocytes.

-Phagocytes can also recognize healthy cells through the “Don’t Eat-Me” signal, which includes CD31, CD47, CD24, PD-L1, and MHC I, to prevent the engulfment of healthy cells.

3

Internalization of ACs [183,184,185,186,187,188,189,190,191,192,193]

-Rac1, a Rho family GTPase, plays a key role in the internalization of ACs during efferocytosis.

-Engulfment receptors initiate downstream signaling pathways that trigger Rac1, leading to cytoskeletal rearrangement and engulfment of the target.

-Different PS receptors, such as BAI1 and Stabilin-2, have established signaling pathways downstream.

-Tim-4 acts as a tethering receptor and promotes efferocytosis by binding ACs on phagocytes, which then use other engulfment receptors, such as integrin, to ingest the ACs. This process is known as two-step engulfment.

-Tethering receptors like Tim-4 can promote efferocytosis without interacting with their co-receptors, but they may have biochemical interactions with co-receptors, such as Mertk.

4

Degradation of ACs [44, 97, 194,195,196,197,198,199,200,201,202]

Phagocytosis degrades ACs by creating phagosomes that become more acidic and eventually join with lysosomes for AC collapse.

-LAP accelerates the process by maturing phagosomes more efficiently, leading to faster AC degradation.

-Phagocytes experience a doubling of intracellular contents during efferocytosis, leading to the release of some contents and adjustments in metabolism to maintain appropriate levels.

-Engulfment receptors recognizing PS and AC-derived sterols activate LXR and PPAR, resulting in altered energy metabolism and cholesterol efflux.

-Alterations in energy metabolism impact the body’s ability to fight inflammation by promoting the generation of anti-inflammatory cytokines and altering glucose transport and lactate release during efferocytosis.

5

Anti-inflammatory responses [203, 204]

-Efferocytosis is associated with an anti-inflammatory response that involves the production of anti-inflammatory cytokines (IL-10 & TGF-β) and the suppression of pro-inflammatory cytokines (TNF-α & IL-1β).

-Nuclear receptors (e.g., LXR & PPAR) are activated by binding to AC-derived ligands, leading to the upregulation of genes involved in efferocytosis and anti-inflammatory responses (e.g., lipid metabolism & anti-inflammatory responses).

  1. ACs Apoptotic cells, BAI1 Brain-specific angiogenesis inhibitor 1, CD Cluster of differentiation, ICAM3 Intercellular adhesion molecule 3, IL Interleukin, LAP LAP-associated phagocytosis, LDL Low-density lipoprotein, LPC Lysophosphatidylcholine, LXR Liver X receptor, MHC Major histocompatibility complex, PD-L1 Programmed death ligand 1, PPAR Peroxisome proliferator-activated receptors, PS Phosphatidylserine, S1P Sphingosine 1-phosphate, Tim-4 T-cell membrane protein 4, TGF-beta Transforming Growth Factor-β, TNF- α Tumor necrosis factor-alpha.